Skip to main content

Lyon Joseph Douglas's Form 4 filing

Corcept Therapeutics Inc (CORT) · filed Jun 7, 2023

Accession no.
0000899243-23-014751
Filed
Jun 7, 2023
Trade date
Jun 6, 2023
Filing delay
1 day
Rule 10b5-1 plan
Not checked

This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $236.0K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Lyon Joseph DouglasCIK 0001817838Officer (Chief Accounting Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 6, 2023Common StockMOption exerciseAcquired+10,000$11.35+$113,50015,132Direct
Jun 6, 2023Common StockSSaleDisposed−10,000$23.60F2−$236,0005,132Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jun 6, 2023Common StockMOption exerciseDisposed−10,000$0.00$056,571Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $23.60 to $23.61. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.

Referenced by the price of 1 transaction in Table I.

Remarks

The power of attorney under which this form was signed is on file with the Commission.

Read the full filing on SEC EDGAR (opens in a new tab)